Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 4 publications
0
4
0
Order By: Relevance
“…19,20 Transvalvular pumps have even been used in combination with biologic and transcatheter aortic valve replacements. [21][22][23] These devices typically pump blood through a cannula placed across the functioning aortic valve, also if the pump itself is placed extracorporeally. 24,25 However, miniaturization of VADs allows direct implantation into the cardiac chamber and allows the use of these pumps as conventional VADs with the outflow cannula passing through the aortic valve.…”
Section: E151mentioning
confidence: 99%
See 1 more Smart Citation
“…19,20 Transvalvular pumps have even been used in combination with biologic and transcatheter aortic valve replacements. [21][22][23] These devices typically pump blood through a cannula placed across the functioning aortic valve, also if the pump itself is placed extracorporeally. 24,25 However, miniaturization of VADs allows direct implantation into the cardiac chamber and allows the use of these pumps as conventional VADs with the outflow cannula passing through the aortic valve.…”
Section: E151mentioning
confidence: 99%
“…However, several potential complications were reported, such as increase in aortic regurgitation during cardiac support, aortic or mitral valve damage, or thrombus formation . Transvalvular pumps have even been used in combination with biologic and transcatheter aortic valve replacements …”
Section: Introductionmentioning
confidence: 99%
“…Ecocardiogram-Doppler examinations during Impella Recover ® LD support have demonstrated absence of pump induced aortic regurgitation even in patients with bioprosthetic aortic valves and pulmonary autografts [6,7]. However cases of functional mitral stenosis secondary to pump placement have been reported [8].…”
Section: Commentsmentioning
confidence: 99%
“…We did not consider other surgical options such as long-term LVAD or heart transplantation, taking into account the possibility of recovery in case of postcardiotomy LOS and the low compliance of this patient. So we, finally, opted for aortic valve replacement with bioprosthesis in order to install the Impella LVAD, as previously described by other authors [2,3]. We chose this device because implantation is minimally invasive, it allows to reduce filling pressures of left cavities with a favorable effect in decongestion of the pulmonary circulation and removal is technically easy, not requiring chest reopening.…”
mentioning
confidence: 99%